-
EP0194851
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0194851
| EP0194851 - Human tumor therapy [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.10.1991 Database last updated on 06.11.2024 | Most recent event Tooltip | 07.07.2007 | Change - inventor | published on 08.08.2007 [2007/32] | Applicant(s) | For all designated states THE WISTAR INSTITUTE 36th Street at Spruce Philadelphia Pennsylvania 19104 / US | [N/P] |
| Former [1986/38] | For all designated states THE WISTAR INSTITUTE 36th Street at Spruce Philadelphia Pennsylvania 19104 / US | Inventor(s) | 01 /
Herlyn, Dorothee 1223 Knox Road Wynnewood PA 19096 / US | [1986/38] | Representative(s) | Hartley, David, et al Withers & Rogers 4 Dyer's Buildings Holborn London, EC1N 2JT / GB | [1989/49] |
| Former [1986/38] | Bannerman, David Gardner Withers & Rogers 4 Dyer's Buildings Holborn London, EC1N 2JT / GB | Application number, filing date | 86301729.9 | 11.03.1986 | [1986/38] | Priority number, date | US19850710233 | 11.03.1985 Original published format: US 710233 | [1986/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0194851 | Date: | 17.09.1986 | Language: | EN | [1986/38] | Type: | A3 Search report | No.: | EP0194851 | Date: | 22.07.1987 | Language: | EN | [1987/30] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 01.06.1987 | Classification | IPC: | A61K39/395, A61K39/00, // (A61K39/00, 31:715) | [1987/30] | CPC: |
A61K39/395 (EP,US);
Y10S424/804 (EP,US)
| C-Set: |
A61K39/395, A61K2300/00 (US,EP);
A61K39/395, A61K31/715 (EP,US) |
| Former IPC [1987/24] | A61K39/395, A61K39/00, // (A61K39/00, 31:715) | ||
| Former IPC [1986/38] | A61K39/00, // (A61K39/00, 31:715) | Designated contracting states | AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE [1986/38] | Title | German: | Therapie der menschlichen Tumore | [1986/38] | English: | Human tumor therapy | [1986/38] | French: | Thérapie de tumeurs humaines | [1986/38] | File destroyed: | 02.03.1998 | Examination procedure | 14.09.1987 | Examination requested [1987/46] | 14.06.1989 | Despatch of a communication from the examining division (Time limit: M04) | 20.10.1989 | Reply to a communication from the examining division | 07.03.1990 | Despatch of a communication from the examining division (Time limit: M04) | 12.07.1990 | Reply to a communication from the examining division | 19.11.1990 | Despatch of a communication from the examining division (Time limit: M06) | 30.05.1991 | Application deemed to be withdrawn, date of legal effect [1991/48] | 03.07.1991 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1991/48] | Fees paid | Renewal fee | 15.03.1988 | Renewal fee patent year 03 | 29.03.1989 | Renewal fee patent year 04 | 19.02.1990 | Renewal fee patent year 05 | 25.02.1991 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] - JOURNAL OF SUPRAMOLECULAR STRUCTURE, vol. 8, 1979, no. suppl. 3, page 281, abstract no. 728, New York, US; C. BELL: "Monoclonal VS polyclonal stimulation by B-1355 polyglucan" | [XP] - INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, vol. 7, no. 3, 1985, page 332, abstract no. 21, Pergamon, New York, US; D. HERLYN et al.: "Stimulation of monoclonal antibody-dependent macrophage-mediated cytotoxicity against human tumors by lentinan" | [XP] - BIOLOGICAL ABSTRACTS, vol. 80, no. 7, 1985, abstract no. 60486, Biological Abstracts Inc., Philadelphia, PA., US; HERLYN et al.: "Monoclonal antibody -dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan", & JPN J CANCER RES. (GANN) 76(1), 37-42, 1985 |